Emin Fadillioglu

Emin Fadillioglu, MD, is a seasoned executive in the pharmaceutical and healthcare sectors, currently serving as Chairman of Eczacıbaşı Evital since September 2022, where the focus is on democratizing healthcare management through digital solutions. As CEO of Eczacıbaşı Pharmaceutical and Industrial Investment since April 2021, Emin oversees three healthcare entities with a total workforce of 1,200 employees. Prior experience includes a significant tenure at GSK as Senior Vice President for Emerging Markets, driving transformational strategies and achieving considerable market growth. Earlier roles at Abbott encompassed leadership in multiple capacities across various regions, notably enhancing organizational performance and fostering an inclusive culture. Emin holds an MBA from Marmara University and a medical degree from İstanbul University-Cerrahpaşa.